Clinical Trials · NCT06178146
Thymosin Alpha-1 for irAE Secondary to ICIs
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Jun Wang
- Enrollment
- 40
- Start date
- Sep 2023
- Locations
- 1 site, China
- Primary endpoint
- Symptoms relieving rate
Search for a command to run...